StonvexLoading…
StonvexCore line items from DLR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.64B | $6.11B | $4.48B | $2.90B |
Operating Income | $267.81M | $658.49M | $545.87M | $407.45M |
Net Income | $179.27M | $1.31B | $1.21B | $1.14B |
EPS (Diluted) | $0.46 | $3.58 | $3.35 | $3.21 |
Total Assets | $48.86B | $49.41B | $48.73B | $48.71B |
Total Liabilities | $23.46B | $24.56B | $23.74B | $23.85B |
Cash & Equivalents | $2.43B | $3.45B | $3.30B | $3.55B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 348.92M | 343.56M | 343.04M | 340.37M |